Two new ACR publications, created in collaboration with the European League Against Rheumatism, aim to improve the treatment of patients with polymyalgia rheumatica (PMR) and introduce new classification criteria for gout…
Serum IGF-1 Tied to Fracture Risk in Elderly Women
NEW YORK (Reuters Health)—A Dutch study confirms that reduced serum levels of insulin-like growth factor-1 (IGF-1) are associated with increased fracture risk in elderly women, but not men. In an Aug. 31 online paper in the Journal of Clinical Endocrinology & Metabolism, Dr. N.C. van Varsseveld, of VU University Medical Center, Amsterdam, and colleagues noted that…
Rheumatologist Michelle Kahlenberg, MD, PhD, Pursues Rural Dream
How are Annie and Abby? That’s a question some patients ask J. Michelle Kahlenberg, MD, PhD, a rheumatologist and assistant professor in the school of medicine at the University of Michigan, who also runs a lupus research lab at the University of Michigan Health System. Patients aren’t asking about her children, but family members of…
Peripheral Nerve Regeneration Insights
A recent investigation provides new details on how macrophages, endothelial cells and Schwann cells coordinate to heal peripheral nerve damage…
2015 ACR Workforce Study Survey Now Open
The American College of Rheumatology Workforce Study Group has been working diligently to develop the 2015 workforce study survey. Ten years have elapsed since the last workforce study, and much has changed since then. This study will help us understand the character and composition of the overall rheumatology workforce, identify demographic and employment trends, and…
More Evidence Dexamethasone Speeds Recovery in Kids with Septic Arthritis
NEW YORK (Reuters Health)—Adding to earlier evidence, a new study finds kids with septic arthritis who are treated with dexamethasone recover faster. “We expected these results based on our previous randomized double-blind controlled study,” Dr. Itay Fogel from Schneider Children’s Medical Center of Israel and Tel Aviv University told Reuters Health by email. “However, the…
Hamstrung by Red Tape, Hospital Operators Buy Their Way into India
NEW DELHI (Reuters)—For nearly two years, Parkway Pantai has delayed the opening of its 450-bed India hospital, the Singapore-based medical firm’s bid to cash in on one of Asia’s fastest growing private healthcare markets, as it waited for the necessary permits. Parkway, a unit of the world’s second largest healthcare group by market value IHH…
Pfizer Loses UK Patent Case over Use of Lyrica Drug for Pain
LONDON (Reuters)—Pfizer suffered a major setback in Britain on Thursday when the High Court in London ruled that claims of patent protection for the use of its $5 billion-a-year drug Lyrica as a pain treatment were invalid. Lyrica, known generically as pregabalin, was originally developed for epilepsy. However, further research showed it could also help patients…
Pacira Sues FDA over Pain Drug Marketing Restrictions
NEW YORK (Reuters)—Pacira Pharmaceuticals Inc. on Tuesday filed a lawsuit seeking a court order allowing it to promote its post-surgery pain drug, Exparel (bupivacaine liposome injectable suspension), for a wide range of surgeries, which the U.S. Food and Drug Administration opposes. The lawsuit, filed in federal court in Manhattan, cites another New York judge’s recent…
Electronic Health Records Software Often Written Without Doctors’ Input
(Reuters Health)—The reason why many doctors find electronic health records (EHR) difficult to use might be that the software wasn’t properly tested, researchers suggests. Current guidelines and industry standards suggest that new EHR software should be tested by at least 15 end users with a clinical background to make sure they are usable and safe…
- « Previous Page
- 1
- …
- 541
- 542
- 543
- 544
- 545
- …
- 796
- Next Page »